Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancer Minji KohJinhong JungJae Ho Jeong Clinical trial 23 April 2021 Pages: 583 - 592
Success and risks of pregnancy after breast cancer Chloe LeprouxValerie SeegersBaptiste Sauterey Clinical trial 21 April 2021 Pages: 593 - 600
Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial Lidia DelrieuAgnès MartinBéatrice Fervers Clinical trial Open access 19 May 2021 Pages: 601 - 613
Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography Quing ZhuFoluso O. AdemuyiwaSteven S. Poplack Clinical trial 10 May 2021 Pages: 615 - 630
Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial Justin StebbingYauheni V. BaranauSunghyun Kim Clinical trial Open access 20 June 2021 Pages: 631 - 640
Effect of surgical complications on outcomes in breast cancer patients treated with mastectomy and immediate reconstruction Emily L. SiegelJunmin WhitingM. Catherine Lee Clinical trial 03 May 2021 Pages: 641 - 648
Machine learning-based image analysis for accelerating the diagnosis of complicated preneoplastic and neoplastic ductal lesions in breast biopsy tissues Shinya SatoSatoshi MakiYohei Miyagi Clinical trial 01 May 2021 Pages: 649 - 659
Serial circulating tumor DNA identification associated with the efficacy and prognosis of neoadjuvant chemotherapy in breast cancer Yidong ZhouYaping XuQiang Sun Clinical trial 18 May 2021 Pages: 661 - 673
Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial Yasuhiro HagiwaraMasataka SawakiNaruto Taira Clinical trial 02 June 2021 Pages: 675 - 683
Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications Ido LaishEitan FriedmanYael Goldberg Clinical trial 04 June 2021 Pages: 685 - 694
Tumor subtypes and survival in male breast cancer Julieta LeoneRachel A. FreedmanJosé Pablo Leone Epidemiology 26 March 2021 Pages: 695 - 702
Breast cancer worry in higher-risk women offered preventive therapy: a UK multicentre prospective study Kelly E. LloydLouise H. HallENGAGE investigators Epidemiology Open access 17 March 2021 Pages: 703 - 712
DNA methylation and breast cancer-associated variants Peh Joo HoRajkumar DorajooJingmei Li Epidemiology 26 March 2021 Pages: 713 - 727
Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer Susanna ThomasMasrura KabirNirmala Pathmanathan Epidemiology 22 March 2021 Pages: 729 - 737
Relationship between body mass index and malignancy rates of MRI-guided breast biopsies: impact of clinicodemographic factors Annie TangCaitlin M. CohanRita A. Mukhtar Epidemiology 27 March 2021 Pages: 739 - 747
Gail model utilization in predicting breast cancer risk in Egyptian women: a cross-sectional study Basem SalehMohamed A. ElhawaryHadeer Mohamed Epidemiology 14 April 2021 Pages: 749 - 758
Multigene assessment of genetic risk for women for two or more breast cancers Jeffrey N. WeitzelJohn KiddThomas P. Slavin Epidemiology 07 April 2021 Pages: 759 - 768
Cardioprotective medication use in Black and white breast cancer survivors Arnethea L. SuttonAshley S. FelixVanessa B. Sheppard Epidemiology 02 April 2021 Pages: 769 - 778
Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach Eng Hooi TanAndrea Li Ann WongBee Choo Tai Epidemiology 04 May 2021 Pages: 779 - 788
Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland L. M. McSorleyM. TharmabalaJ. M. Walshe Epidemiology 09 April 2021 Pages: 789 - 798
Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2− metastatic breast cancer Kristoffer B. KristensenIda Marie Nedergaard ThomsenAnders Bonde Jensen Epidemiology 10 April 2021 Pages: 799 - 809
Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk Ksenija StrojnikMateja KrajcAna Blatnik Epidemiology Open access 23 April 2021 Pages: 811 - 820
Letter to the editor regarding: ‘Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis’ Yuwei WangAlexandra J. van den BroekMarjanka K. Schmidt Letter to the Editor 16 June 2021 Pages: 821 - 823
COVID-19 vaccination and breast cancer surgery timing Gary KoSusy HotaTulin D. Cil Letter to the Editor 22 June 2021 Pages: 825 - 826
Sanchez et al. respond to Austin-Datta et al. Tiffany R. SanchezJeanine M. GenkingerJames V. Lacey Jr. Letter to the Editor 25 June 2021 Pages: 827 - 828
